1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Vivo Capital, LLC Buys Selecta Biosciences Inc, Verona Pharma PLC, Aurinia Pharmaceuticals Inc, Sells Advanced Accelerator Applications SA

August 02, 2017 | About:

Investment company Vivo Capital, LLC buys Selecta Biosciences Inc, Verona Pharma PLC, Aurinia Pharmaceuticals Inc, Biohaven Pharmaceutical Holding Co, sells Advanced Accelerator Applications SA during the 3-months ended 2017-06-30, according to the most recent filings of the investment company, Vivo Capital, LLC. As of 2017-06-30, Vivo Capital, LLC owns 24 stocks with a total value of $390 million. These are the details of the buys and sells.

For the details of Vivo Capital, LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Vivo+Capital%2C+LLC

These are the top 5 holdings of Vivo Capital, LLC
  1. Aclaris Therapeutics Inc (ACRS) - 2,858,569 shares, 23.14% of the total portfolio.
  2. Ascendis Pharma A/S (ASND) - 1,766,832 shares, 14.64% of the total portfolio.
  3. Nabriva Therapeutics AG (NBRV) - 4,021,559 shares, 12.58% of the total portfolio.
  4. Nabriva Therapeutics AG (NBRV) - 4,021,559 shares, 12.58% of the total portfolio.
  5. Codexis Inc (CDXS) - 5,294,825 shares, 8.61% of the total portfolio.
New Purchase: Selecta Biosciences Inc (SELB)

Vivo Capital, LLC initiated holdings in Selecta Biosciences Inc. The purchase prices were between $12.06 and $20, with an estimated average price of $14.64. The stock is now traded at around $18.09. The impact to the portfolio due to this purchase was 6.63%. The holdings were 1,119,189 shares as of 2017-06-30.

New Purchase: Verona Pharma PLC (VRNA)

Vivo Capital, LLC initiated holdings in Verona Pharma PLC. The purchase prices were between $11.4 and $16.26, with an estimated average price of $13.27. The stock is now traded at around $12.31. The impact to the portfolio due to this purchase was 2.45%. The holdings were 704,225 shares as of 2017-06-30.

New Purchase: Biohaven Pharmaceutical Holding Co Ltd (BHVN)

Vivo Capital, LLC initiated holdings in Biohaven Pharmaceutical Holding Co Ltd. The purchase prices were between $17.5 and $26.8, with an estimated average price of $22.98. The stock is now traded at around $23.63. The impact to the portfolio due to this purchase was less than 0.01%. The holdings were 1,976,818 shares as of 2017-06-30.

Added: Aurinia Pharmaceuticals Inc (AUPH)

Vivo Capital, LLC added to the holdings in Aurinia Pharmaceuticals Inc by 68.86%. The purchase prices were between $5.94 and $7.68, with an estimated average price of $6.76. The stock is now traded at around $6.26. The impact to the portfolio due to this purchase was 0.75%. The holdings were 1,013,149 shares as of 2017-06-30.



Here is the complete portfolio of Vivo Capital, LLC. Also check out:

1. Vivo Capital, LLC's Undervalued Stocks
2. Vivo Capital, LLC's Top Growth Companies, and
3. Vivo Capital, LLC's High Yield stocks
4. Stocks that Vivo Capital, LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


DANGORDON11-17-18 REV EARNINGS GROWTH
DBrizanhi yield 2018Nov16 1118p
DBrizanfinancial 2018Nov16 1101p
DBrizanfinancial
DBrizanall 2018Nov16 1034p
DBrizanCDN2018Nov16 1019p
filip2001sandp500
sathyagajjala15value
ChabiPaul's 7's
rael2222CUCK AKRE 1
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK